What is LGBTQ+ Pride Month? Here's everything you need to know, from its origins at New York City's Stonewall Inn to the ...

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally. The company offers molecular ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million. The company’s full-year revenue guidance of $815 million at the ...

The latest price target for Myriad Genetics (NASDAQ:MYGN) was reported by Goldman Sachs on April 17, 2025. The analyst firm set a price target for $14.00 expecting MYGN to rise to within 12 months ...